First Time Loading...

Pacira Biosciences Inc
NASDAQ:PCRX

Watchlist Manager
Pacira Biosciences Inc Logo
Pacira Biosciences Inc
NASDAQ:PCRX
Watchlist
Price: 26.985 USD -0.83% Market Closed
Updated: May 6, 2024

Pacira Biosciences Inc
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Pacira Biosciences Inc
Cash from Operating Activities Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Pacira Biosciences Inc
NASDAQ:PCRX
Cash from Operating Activities
$154.6m
CAGR 3-Years
26%
CAGR 5-Years
26%
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Cash from Operating Activities
$23.2B
CAGR 3-Years
-1%
CAGR 5-Years
1%
CAGR 10-Years
2%
Bristol-Myers Squibb Co
NYSE:BMY
Cash from Operating Activities
$13.7B
CAGR 3-Years
-1%
CAGR 5-Years
17%
CAGR 10-Years
12%
Pfizer Inc
NYSE:PFE
Cash from Operating Activities
$8.7B
CAGR 3-Years
-18%
CAGR 5-Years
-11%
CAGR 10-Years
-7%
Merck & Co Inc
NYSE:MRK
Cash from Operating Activities
$13B
CAGR 3-Years
5%
CAGR 5-Years
3%
CAGR 10-Years
1%
Eli Lilly and Co
NYSE:LLY
Cash from Operating Activities
$3.7B
CAGR 3-Years
-22%
CAGR 5-Years
-7%
CAGR 10-Years
-4%

See Also

What is Pacira Biosciences Inc's Cash from Operating Activities?
Cash from Operating Activities
154.6m USD

Based on the financial report for Dec 31, 2023, Pacira Biosciences Inc's Cash from Operating Activities amounts to 154.6m USD.

What is Pacira Biosciences Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
26%

Over the last year, the Cash from Operating Activities growth was 6%. The average annual Cash from Operating Activities growth rates for Pacira Biosciences Inc have been 26% over the past three years , 26% over the past five years .